Skip to content
Screener

Sionna Therapeutics SION Price / book

Price / book at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
6.2×-0.5×
AbbVie logo
AbbVieABBV
261×+221×
Achieve Life Sciences logo
Achieve Life SciencesACHV
14.7×+5.6×
Septerna, Inc. logo
Septerna, Inc.SEPN
3.9×+2.6×
RFL
Rafael Holdings, Inc.RFL
0.9×+0.1×
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
1.1×+0.7×

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$203.46M-77.0%
Enterprise value$147.55M-82.7%

Returns & leverage

See full
Return on equity-26.7%—
Debt / equity0×0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from Sionna Therapeutics’s reported figures.

market cap/total stockholders equity=6.3×

Based on the most recent quarter.

The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 7:17 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033876

FAQ

What is Sionna Therapeutics's price / book?
Sionna Therapeutics (SION) reported price / book of 6.3× in Q1 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Sionna Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude